BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8356986)

  • 1. Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut.
    Heimer R; Kaplan EH; Khoshnood K; Jariwala B; Cadman EC
    Am J Med; 1993 Aug; 95(2):214-20. PubMed ID: 8356986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV prevalence among intravenous drug users: model-based estimates from New Haven's legal needle exchange.
    Kaplan EH; Heimer R
    J Acquir Immune Defic Syndr (1988); 1992; 5(2):163-9. PubMed ID: 1732509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV incidence among needle exchange participants: estimates from syringe tracking and testing data.
    Kaplan EH; Heimer R
    J Acquir Immune Defic Syndr (1988); 1994 Feb; 7(2):182-9. PubMed ID: 8301530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syringe source, use, and discard among injection-drug users in New Haven, Connecticut.
    Khoshnood K; Blankenship KM; Pollack HA; Roan CT; Altice FL
    AIDS Public Policy J; 2000; 15(3-4):88-94. PubMed ID: 12189714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV incidence among New Haven needle exchange participants: updated estimates from syringe tracking and testing data.
    Kaplan EH; Heimer R
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Oct; 10(2):175-6. PubMed ID: 7552482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A decline in HIV-infected needles returned to New Haven's needle exchange program: client shift or needle exchange?
    Kaplan EH; Khoshnood K; Heimer R
    Am J Public Health; 1994 Dec; 84(12):1991-4. PubMed ID: 7998644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of increasing syringe availability on syringe-exchange use and HIV risk: Connecticut, 1990-2001.
    Heimer R; Clair S; Teng W; Grau LE; Khoshnood K; Singer M
    J Urban Health; 2002 Dec; 79(4):556-70. PubMed ID: 12468675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syringe and needle exchange as HIV/AIDS prevention for injection drug users.
    Watters JK; Estilo MJ; Clark GL; Lorvick J
    JAMA; 1994 Jan; 271(2):115-20. PubMed ID: 8264065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community coverage and HIV prevention: assessing metrics for estimating HIV incidence through syringe exchange.
    Heimer R
    Int J Drug Policy; 2008 Apr; 19 Suppl 1(Suppl 1):S65-73. PubMed ID: 18207726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syringe and needle exchange programs: Part I.
    Schwartz RH
    South Med J; 1993 Mar; 86(3):318-22. PubMed ID: 8451672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Legal access to needles and syringes/needle exchange programmes versus HIV counselling and testing to prevent transmission of HIV among intravenous drug users: a comparative study of Denmark, Norway and Sweden.
    Amundsen EJ; Eskild A; Stigum H; Smith E; Aalen OO
    Eur J Public Health; 2003 Sep; 13(3):252-8. PubMed ID: 14533729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study finds legalizing needles reduces HIV risk.
    AIDS Policy Law; 1995 Sep; 10(17):1, 11. PubMed ID: 11362806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of HIV-infected syringes during a syringe-exchange program.
    Heimer R; Kaplan EH; Cadman EC
    N Engl J Med; 1992 Dec; 327(26):1883-4. PubMed ID: 1448131
    [No Abstract]   [Full Text] [Related]  

  • 14. Syringe access for injection drug users in Rhode Island.
    Boutwell A; Rich JD
    Med Health R I; 2004 Jan; 87(1):15-6. PubMed ID: 14989076
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of needle exchange programs in HIV prevention.
    Vlahov D; Junge B
    Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):75-80. PubMed ID: 9722812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of HIV-1 DNA in needle/syringes, paraphernalia, and washes from shooting galleries in Miami: a preliminary laboratory report.
    Shah SM; Shapshak P; Rivers JE; Stewart RV; Weatherby NL; Xin KQ; Page JB; Chitwood DD; Mash DC; Vlahov D; McCoy CB
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Mar; 11(3):301-6. PubMed ID: 8603266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public health interventionists, penny capitalists, or sources of risk?: assessing street syringe sellers in Hartford, Connecticut.
    Stopka TJ; Singer M; Santelices C; Eiserman J
    Subst Use Misuse; 2003 Jul; 38(9):1345-77. PubMed ID: 12908815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consequences of a restrictive syringe exchange policy on utilisation patterns of a syringe exchange program in Baltimore, Maryland: Implications for HIV risk.
    Sherman SG; Patel SA; Ramachandran DV; Galai N; Chaulk P; Serio-Chapman C; Gindi RM
    Drug Alcohol Rev; 2015 Nov; 34(6):637-44. PubMed ID: 25919590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of a pilot study on needle and syringe exchange program among injecting drug users in a community in Guangdong, China].
    Lin P; Fan ZF; Yang F; Wu ZY; Wang Y; Liu YY; Ming ZQ; Li WJ; Luo W; Fu XB; Mai XR; Xu RH; Feng WY; He Q
    Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Sep; 38(5):305-8. PubMed ID: 15498241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Needle syringe acquisition and HIV prevention among injecting drug users: a treatise on the "good" and "not so good" public health practices in South Asia.
    Panda S; Sharma M
    Subst Use Misuse; 2006; 41(6-7):953-77. PubMed ID: 16809181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.